![]() |
|
|
Forward to a colleague |
||
Access Full Stories NanoSight's particle size analysers have found in a new home in the laboratories of 'nanotoxicologists' due to their ease of use and rapid ability to size and count individual nanoparticles... Read Industry news in brief - week 47 LabTechnologist.com brings you a round up of recent industry news, with developments at Advanced Instruments, Aperio, Applied Biosystems, Beckman Coulter, Bruker, Invitrogen, Roche, TCS Cellworks and Thermo Fisher... Read Simultaneous measurement of multiple cytokines Researchers at Randox, UK, have developed a biochip that enables the simultaneous measurement of 12 human cytokines from human serum samples enabling cytokine studies to be conducted faster... Read Researcher recognised for studies in drug delivery Dr Mitsuru Hashida is hoping his studies into drug delivery will be useful for the pharmaceutical industry... Read Caliper launches combo drug testing services Caliper Life Sciences has launched new testing services that will help researchers weed out unsuitable combination drug therapies in the preclinic... Read |
||||||||||||||||||
All News Headlines for: November | October | September |
||||||||||||||||||
ZIC®-pHILIC Separation of Polar and Hydrophilic Compounds SeQuant is presenting a new analytical methodology for separation of nucleotides at high pH using gradient elution and ammonium carbonate buffer. Separation is performed on a polymer based ZIC®-pHILIC column and quantification by FTMS - negative ESI-MS detection... Click Here | ||||||||||||||||||
|
Related Industry News Merck turns to India for latest R&D partnership Merck & Co. has turned to India's Nicholas Piramal (NPIL) for its latest research collaboration, as the preclinical offshoring trend persists... Read Formulation tech goes Enterion The Enterion capsule is quickly becoming big pharma's new best friend as the technology helps drug companies assess the feasibility of oral modified release formulations... Read South Africa 'underutilised' for clinical trials While India, the Asia-Pacific, Eastern Europe and Latin America are all gaining recognition as potential new hot spots, South Africa remains 'underutilised as a clinical trial destination,' according to a prominent... Read Pfizer, Nektar agreement not so sweet after all? Pfizer yesterday announced a multi-million dollar pay-off to ex-partner Nektar Therapeutics, but the details of the deal reveal not only Nektar's concerns for its future, but also that Pfizer is still keeping its... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||